ResearcherSickle Cell Institute Chhattisgarh, RaipurNo recent work listed
Lakkakula VKS Bhaskar
Matched on ORCID iD 0000-0003-2977-6454; OpenAlex author ID A5005705973. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2019: 4 papers
Papers 4
- Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles. Co-author DOI 10.1016/j.semcancer.2018.09.011↗
- Nanoparticles in Pancreatic Cancer Imaging and Therapy. Last author DOI 10.1615/critrevoncog.2019031519↗
- DNA Fingerprint Technology: Its Application in Detecting Pancreatic Cancer. Co-author DOI 10.1615/critrevoncog.2019031603↗
- A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy. Co-author DOI 10.2174/1389200220666191122104955↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gayathri Chalikonda · 3 shared papers, 2019 · strength 0.41
- Paper Nanoparticles in Pancreatic Cancer Imaging and Therapy. DOI 10.1615/critrevoncog.2019031519↗
- Paper DNA Fingerprint Technology: Its Application in Detecting Pancreatic Cancer. DOI 10.1615/critrevoncog.2019031603↗
- Paper A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy. DOI 10.2174/1389200220666191122104955↗
- Saikrishna Lakkakula · 3 shared papers, 2019 · strength 0.37
- Paper Nanoparticles in Pancreatic Cancer Imaging and Therapy. DOI 10.1615/critrevoncog.2019031519↗
- Paper A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy. DOI 10.2174/1389200220666191122104955↗
- Paper Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles. DOI 10.1016/j.semcancer.2018.09.011↗
- Ganji Purnachandra Nagaraju · 2 shared papers, 2019 · strength 0.23
- Smaranika Pattnaik · 1 shared paper, 2019 · strength 0.11
- Henu Kumar Verma · 1 shared paper, 2019 · strength 0.11
- Nagendra Sastry Yarla · 1 shared paper, 2019 · strength 0.10
- Batoul Farran · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.